<--- Back to Details
First PageDocument Content
Chemistry / Purines / Gilead Sciences / Organofluorides / Hepatitis B / Entecavir / Adefovir / Lamivudine / Hepatocellular carcinoma / Medicine / Antivirals / Hepatology
Date: 2014-04-30 06:48:47
Chemistry
Purines
Gilead Sciences
Organofluorides
Hepatitis B
Entecavir
Adefovir
Lamivudine
Hepatocellular carcinoma
Medicine
Antivirals
Hepatology

Hepatitis B is a Treatable Disease! Harry L.A. Janssen Dept. of Gastroenterology & Hepatology Erasmus University Medical Center Rotterdam The Netherlands

Add to Reading List

Source URL: www.hepbcppa.org

Download Document from Source Website

File Size: 577,00 KB

Share Document on Facebook

Similar Documents

Microsoft Word - GOCERdoc

Microsoft Word - GOCERdoc

DocID: 1kHhC - View Document

Journal of Hepatology–540 www.elsevier.com/locate/jhep Special article  EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B

Journal of Hepatology–540 www.elsevier.com/locate/jhep Special article EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B

DocID: 1fJIH - View Document

JCPJCP CE Activities Log onto https://accp1.inreachce.com/ to access these activities. Clinical Response JCP - August, 2014: Positive Clinical Response to Clopidogrel is Independent of Paraoxonase I Q192R and CYP2C19 Gen

JCPJCP CE Activities Log onto https://accp1.inreachce.com/ to access these activities. Clinical Response JCP - August, 2014: Positive Clinical Response to Clopidogrel is Independent of Paraoxonase I Q192R and CYP2C19 Gen

DocID: 1ftMp - View Document

ESA Clinical WeekendDr Eleanor Thong Endocrine Registrar The Alfred, VIC Co-authors: Prof Duncan Topliss

ESA Clinical WeekendDr Eleanor Thong Endocrine Registrar The Alfred, VIC Co-authors: Prof Duncan Topliss

DocID: 14e9a - View Document

Addendum to ACERH Research Report No.7  Original statement: Entecavir is subsidised only as a second line therapy for patients who have failed

Addendum to ACERH Research Report No.7 Original statement: Entecavir is subsidised only as a second line therapy for patients who have failed

DocID: XGhU - View Document